Scripps Cardiovascular Atherosclerosis: Prediction, Prevention and Management 2023 (Videos + PDF)

Comprehensive ASCVD Prevention and Cardiovascular Risk Management Update

The Scripps Cardiovascular Atherosclerosis: Prediction, Prevention and Management 2023 conference is a focused educational program dedicated to the prevention, diagnosis, risk stratification, and treatment of atherosclerotic cardiovascular disease (ASCVD). This course provides clinicians with the latest evidence-based strategies for reducing cardiovascular risk through lifestyle modification, precision medicine, lipid management, hypertension control, obesity treatment, genetic testing, and emerging pharmacologic therapies.

As ASCVD remains the leading cause of death worldwide and one of the largest contributors to healthcare expenditures, effective prevention and risk-factor management have become essential components of modern cardiovascular care. Through expert-led presentations and practical clinical discussions, this symposium helps healthcare professionals translate the latest scientific advances into everyday patient care.

Product Details

Title: Scripps Cardiovascular Atherosclerosis: Prediction, Prevention and Management 2023
Format: 13 Videos + 1 PDF
File Size: 2.36 GB
Year: 2023
Educational Format: Conference Recordings + Slides

Course Overview

Despite significant advances in cardiovascular medicine, ASCVD remains responsible for millions of deaths annually and continues to be a major source of disability and healthcare costs. Many cardiovascular events are preventable through earlier risk identification, appropriate pharmacologic therapy, lifestyle interventions, and aggressive management of modifiable risk factors.

This conference focuses on modern preventive cardiology and reviews contemporary approaches to:

• Cardiovascular risk prediction
• Lipid disorders
• Hypertension management
• Obesity treatment
• Type 2 diabetes management
• Familial hypercholesterolemia
• Coronary artery imaging
• Genomics and personalized medicine
• Heart failure prevention
• Nonalcoholic fatty liver disease (NAFLD)
• Cardiovascular implications of testosterone therapy

The curriculum emphasizes practical implementation of current guidelines and emerging therapies that improve cardiovascular outcomes.

Target Audience

This course is designed for:

Physicians

• Cardiologists
• Preventive Cardiologists
• Endocrinologists
• Internists
• Family Medicine Physicians
• General Practitioners

Advanced Practice Providers

• Nurse Practitioners (NP)
• Physician Assistants (PA)

Nursing Professionals

• Registered Nurses
• Cardiovascular Nurses

Trainees

• Cardiology Fellows
• Internal Medicine Residents
• Endocrinology Fellows

Learning Objectives

Upon completion of this activity, participants should be able to:

• Apply principles of personalized medicine to ASCVD prevention
• Utilize current hypertension management strategies
• Integrate GLP-1 receptor agonists into obesity and diabetes treatment
• Assess cardiovascular risk using biomarkers and imaging
• Interpret genetic testing for familial hypercholesterolemia
• Implement current dyslipidemia treatment guidelines
• Evaluate emerging lipid-lowering therapies
• Apply evidence-based heart failure prevention strategies
• Understand the cardiovascular implications of NAFLD
• Utilize coronary CT imaging appropriately in cardiovascular risk assessment

Major Topics Covered

❤️ Atherosclerotic Cardiovascular Disease (ASCVD)

Core Concepts

• Pathophysiology of Atherosclerosis
• Risk Assessment
• Primary Prevention
• Secondary Prevention
• Long-Term Disease Management

Clinical Focus

• Reducing Cardiovascular Events
• Improving Survival
• Personalized Prevention Strategies

🧬 Personalized Medicine & Cardiovascular Genomics

Precision Prevention

Advances in genomics are transforming cardiovascular risk prediction and treatment selection.

Topics Covered

• Genetic Risk Assessment
• Polygenic Risk Scores
• Precision Cardiovascular Medicine
• Pharmacogenomics
• Individualized Treatment Strategies

Clinical Applications

• Early Risk Identification
• Personalized Prevention Programs

🩺 Hypertension Management

Contemporary Blood Pressure Control

Topics Include

• Updated Hypertension Guidelines
• Blood Pressure Targets
• Resistant Hypertension
• Combination Therapy Strategies
• Cardiovascular Risk Reduction

Clinical Relevance

Hypertension remains one of the most important modifiable ASCVD risk factors.

💉 GLP-1 Receptor Agonists

Obesity and Type 2 Diabetes Management

One of the most rapidly evolving areas of preventive cardiology.

Topics Covered

• Semaglutide
• Tirzepatide
• Weight Management
• Cardiovascular Outcome Benefits
• Diabetes Risk Reduction

Clinical Impact

• Reduction in Major Adverse Cardiovascular Events (MACE)
• Improved Metabolic Health

🫀 High-Sensitivity Troponin in Risk Assessment

Emerging Biomarkers

Areas Covered

• High-Sensitivity Troponin Testing
• Risk Stratification
• Subclinical Cardiovascular Disease
• Biomarker Integration

Clinical Applications

• Early Detection of Risk
• Personalized Prevention Approaches

🧬 Familial Hypercholesterolemia (FH)

Genetic Lipid Disorders

Topics Include

• Genetic Testing
• Cascade Screening
• Diagnosis of FH
• Family-Based Prevention

Clinical Importance

Early diagnosis significantly reduces future cardiovascular events.

🩸 Dyslipidemia Management

Modern Lipid Therapy

Guideline-Based Treatment

• LDL-C Targets
• Risk-Based Therapy
• Statins
• Ezetimibe
• Combination Therapy

Advanced Lipid Assessment

• ApoB
• Lipoprotein(a)
• Residual Risk Evaluation

💊 Emerging Lipid-Lowering Therapies

Novel Pharmacologic Agents

Topics Covered

• PCSK9 Inhibitors
• Inclisiran
• Bempedoic Acid
• Future Lipid-Lowering Therapies

Clinical Benefits

• LDL Reduction
• ASCVD Event Reduction
• Personalized Treatment Selection

❤️ Heart Failure Prevention and Management

Cardiovascular Risk Reduction

Topics Include

• Heart Failure Guidelines
• SGLT2 Inhibitors
• Risk-Based Prevention
• Early Intervention Strategies

Clinical Applications

• Prevention of Disease Progression
• Reduction in Hospitalizations

🌿 Nutritional Supplements and Cardiovascular Health

Evidence-Based Review

Areas Covered

• Omega-3 Fatty Acids
• Nutritional Supplements
• Dietary Strategies
• Prevention Claims vs Evidence

Clinical Perspective

Evaluating what truly benefits cardiovascular outcomes.

🖥️ Coronary CT Imaging

Non-Invasive Cardiovascular Evaluation

Topics Include

• Coronary Artery Calcium (CAC) Scoring
• Coronary CT Angiography (CCTA)
• Risk Stratification
• Imaging-Based Prevention

Clinical Benefits

• Earlier Detection of Coronary Disease
• Improved Preventive Decision Making

🧫 Nonalcoholic Fatty Liver Disease (NAFLD)

Cardiometabolic Disease Connection

Topics Covered

• Epidemiology
• Pathophysiology
• Cardiovascular Risk Associations
• Management Strategies

Clinical Significance

NAFLD is increasingly recognized as a major cardiovascular risk enhancer.

👨 Testosterone Therapy and Cardiovascular Risk

Contemporary Evidence Review

Topics Include

• Testosterone Replacement Therapy
• Cardiovascular Safety
• Clinical Trial Data
• Risk-Benefit Assessment

Practical Considerations

• Patient Selection
• Monitoring Strategies

📚 Educational Highlights

Preventive Cardiology Focus

Comprehensive review of ASCVD prevention and risk-factor management.

Practical Clinical Application

Guideline-based recommendations that can be implemented immediately.

Emerging Therapies

Coverage of the latest advances in:

• GLP-1 Agonists
• PCSK9 Inhibitors
• Precision Medicine
• Coronary CT Imaging

Evidence-Based Curriculum

Built around current clinical trials and prevention guidelines.

Who Should Attend?

Ideal for:

• Cardiologists
• Endocrinologists
• Internists
• Preventive Cardiologists
• Family Physicians
• General Practitioners
• Nurse Practitioners
• Physician Assistants
• Cardiovascular Nurses
• Cardiology Fellows

Key Educational Benefits

✔ Comprehensive ASCVD Prevention Review

✔ Precision Cardiovascular Medicine

✔ Hypertension Management Updates

✔ GLP-1 Therapy and Obesity Medicine

✔ Dyslipidemia and Lipid-Lowering Strategies

✔ Familial Hypercholesterolemia Education

✔ Coronary CT Imaging Applications

✔ Heart Failure Prevention

✔ NAFLD and Cardiovascular Risk

✔ Testosterone Therapy Evidence Review

✔ Case-Based Clinical Discussions

✔ Evidence-Based Treatment Recommendations

Clinical & Educational Value

The Scripps Cardiovascular Atherosclerosis: Prediction, Prevention and Management 2023 conference provides a modern, comprehensive review of preventive cardiology and ASCVD management. Participants gain practical knowledge in risk prediction, lipid management, hypertension control, obesity treatment, genomics, advanced imaging, and emerging therapies, enabling them to deliver more effective, personalized cardiovascular care.

 Topics:

• brochure_lipids23_compressed.pdf
• Advanced Hypertension Management.mp4
• Bio-Identical Hormones and Testosterone Supplementation.mp4
• Evaluate Horrible Cholesterol, Lipoprotein A Prevalence, Impact, and Novel Therapeutics.mp4
• Genetic Testing for Familial Hypercholesterolemia When to Test, Whom to Test.mp4
• New Concepts in Dyslipidemia Dispelling 10 Truths About Lipids.mp4
• Non-HDL Targets for Risk Reduction.mp4
• Nonalcoholic Fatty Liver Disease and Its Contribution to CV Disease.mp4
• Obesity and Diabetic Pharmacotherapy Are You Ready for GLP-1 Agonists.mp4
• Panel Discussion Q&A 1.mp4
• Panel Discussion Q&A 2.mp4
• Panel Discussion Q&A 3.mp4
• Panel Discussion Q&A 4.mp4
• Supplements in Primary and Secondary Prevention of ASCVD.mp4